/
RSS Feed
LOS ANGELES—A recombinant form of the human hormone relaxin — active in pregnancy to optimise the mother’s cardiovascular capacity — may help patients hospitalised for acute heart failure, according to findings discussed at the American Heart Association’s 2012 Scientific Sessions held in Los Angeles. Sarah Maxwell hears about results from the RELAX study from author Dr John Teerlink, Professor of Medicine at the University of California, San Francisco and commentator Dr Milton Packer, Chair and Professor of Clinical Sciences at the University of Texas Southwestern in Dallas.
LISTEN
[audio:https://www.audiomedica.com/podcasting/aha/121116JohnTeerlinkMiltonPackerPODCASTLoRes.mp3]
